Cato BioVentures: A US-based venture capital firm investing in life sciences and clinical development.
5
Operating
1990
Durham, NC, US
Cato BioVentures is a venture capital firm focused on investing in life sciences, clinical development, regulatory affairs, and manufacturing sectors. Based in the United States, the firm primarily targets seed-stage investments, with a particular emphasis on early-stage companies in the healthcare and biotechnology industries.
The firm's portfolio includes PluroGen Therapeutics, which has raised $1.7 million. Cato BioVentures leverages its expertise in clinical development and regulatory affairs to provide strategic support to its portfolio companies, helping them navigate the complex landscape of healthcare innovation and commercialization.
Portfolio Snapshot
Recorded participation and recipient operating status, not current holdings or realized exits
Recorded Recipients1
Top Investment Stages
Seed1 (100.0%)
Stage Mix
Seed 100%
Concentration shown as share of disclosed investments by stage.
